Free vaccine programs to cocoon high-risk infants and children against influenza and pertussis

Judith A Guzman-Cottrill1, Carrie A Phillipi, Susan A Dolan

  • 1Department of Pediatrics, Oregon Health and Science University, Portland, OR 97239-3098, USA. guzmanco@ohsu.edu

Insights

Cocooning immunization strategy involves vaccinating infants' close contacts to protect vulnerable children. This study examines free vaccine programs in children's hospitals to implement this approach.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Cocooning is an adult immunization strategy to protect infants and high-risk children.
  • It involves immunizing the close contacts of these vulnerable populations.
  • This strategy aims to limit pathogen exposure and transmission.

Purpose of the Study:

  • To explore the adoption of free vaccine programs in US children's hospitals.
  • To share institutional experiences in implementing free vaccine programs for patient contacts.
  • To assess the feasibility and impact of cocooning immunization strategies.

Main Methods:

  • Review of existing literature on cocooning strategies.
  • Analysis of free vaccine program adoption in children's hospitals.
  • Case study of a specific institution's implementation experience.

Main Results:

  • Limited widespread adoption of free vaccine programs for cocooning.
  • Challenges identified in program implementation and sustainability.
  • Positive outcomes reported in institutions with established programs.

Conclusions:

  • Cocooning immunization is a valuable strategy for protecting vulnerable children.
  • Barriers to implementing free vaccine programs need to be addressed.
  • Further research and policy support are needed to promote wider adoption.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...